An open trial comparing isradipine with hydralazine and methyl dopa in the treatment of patients with severe pre-eclampsia.

Placental blood flow is decreased in pre-eclampsia and is worsened by decreasing blood pressure. Hydralazine, which causes vasodilatation, does not affect placental bed vessels. Calcium channel blockers (like isradipine) are vasodilators that do affect placental bed vessels and should improve blood flow even while decreasing blood pressure. The aim of the study was to determine if isradipine (parenteral and oral) was better than parenteral hydralazine and oral methyl dopa in severe pre-eclampsia in achieving better control of blood pressure. The study was a prospective randomised trial performed at The University Hospital of the West Indies. The sample consisted of 39 women with severe pre-eclampsia. Variables examined consisted of blood pressure before and after treatment, the increment in gestational age at delivery related to treatment, fetal Apgar score and birth weight. There were no significant differences in any of these variables between the two groups. Isradipine was as effective as hydralazine in reducing maternal blood pressure and in prolonging pregnancy.

[1]  T. Forrester,et al.  Relationship between maternal nutritional status and infant’s weight and body proportions at birth , 1997, European Journal of Clinical Nutrition.

[2]  R. Priest,et al.  The hypertensive disorders of pregnancy , 1995 .

[3]  K. Maršál,et al.  Calcium channel blockade (isradipine) in treatment of hypertension in pregnancy: a randomized placebo-controlled study. , 1995, American journal of obstetrics and gynecology.

[4]  C. Redman,et al.  Management of pre-eclampsia , 1993, The Lancet.

[5]  S. Lurie,et al.  Nifedipine in the Treatment of Severe Preeclampsia , 1991, Obstetrics and gynecology.

[6]  U. Ekblad,et al.  Single dose of nifedipine in normotensive pregnancy: nifedipine concentrations, hemodynamic responses, and uterine and fetal flow velocity waveforms. , 1990, Obstetrics and gynecology.

[7]  S. Kennedy,et al.  Atenolol in essential hypertension during pregnancy. , 1990, BMJ.

[8]  T. Hedner,et al.  Renal and hemodynamic effects of isradipine in essential hypertension. , 1989, The American journal of medicine.

[9]  S. Lindow,et al.  The effect of sublingual nifedipine on uteroplacental blood flow in hypertensive pregnancy , 1988, British journal of obstetrics and gynaecology.

[10]  G. Walker,et al.  MATERNAL MORTALITY IN JAMAICA , 1986, The Lancet.

[11]  C. Redman,et al.  Antihypertensive drugs in pregnancy. , 1985, Clinics in perinatology.

[12]  R. H. Philpott,et al.  Effect of dihydralazine on the fetus in the treatment of maternal hypertension. , 1980, Obstetrics and gynecology.

[13]  K. Andersson,et al.  Effects of nifedipine on human placental arteries. , 1984, Gynecologic and obstetric investigation.

[14]  N. Lunell,et al.  Acute effect of dihydralazine on uteroplacental blood flow in hypertension during pregnancy. , 1983, Gynecologic and obstetric investigation.